• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 05-Mar-2021 EOD, Market Closed
SENSEX
50,405.32
-440.76 (-0.87%)
NIFTY
14,938.10
-142.65 (-0.95%)
    No Companies Visited

Back to news list
  • Sun Pharma rises 13% in four days

    Sun Pharmaceutical Industries jumped 6.79% to Rs 518.05 on BSE, extending its winning run to fourth consecutive trading session.

    The stock has surged 13.4% in four trading days from its previous closing low of Rs 465.75 on 29 October 2020. The stock is 9% away from its 52-week high of Rs 564.90 reported on 28 August 2020.

    The counter saw a strong demand after the drug major posted Q2 September 2020 results on Tuesday (3 November 2020). The company's consolidated net profit surged 70.36% to Rs 1,812.79 crore on a 6.41% increase in revenue from operations to Rs 8,458.77 crore in Q2 September 2020 over Q2 September 2019.

    Consolidated profit before tax (PBT) soared 33.75% to Rs 1,917.18 crore in Q2 September 2020 as against Rs 1,433.38 crore in Q2 September 2019. Current tax expense for the quarter fell 3.36% to Rs 257.08 crore as against Rs 266.03 crore in Q2 September 2019. The firm said it continues to monitor the impact of COVID-19 on its business, including its impact on customers, supply-chain, employees and logistics.

    Consolidated EBITDA rose 30% YoY to Rs 2,099 crore over Q2 September 2019. EBITDA margin came at 24.8% driven by gradual recovery in overall business coupled with control on expenses.

    Sun Pharma's India sales stood at Rs 2531 crore, rising 1% from Q2 September 2019. The company's US finished dosage sales stood at $335 million, flat over Q2 September 2019 and up by 19% from Q1 June 2020. Emerging markets sales came at $210 million, up by 4.5% year on year and 21% higher than Q1 June 2020.

    R&D investments were at Rs 613 crore (7.2% of sales) in Q2 September 2020, rising 25.6% from Rs 488 crores (6.1% of sales) in Q2 September 2019.

    Commenting on company's performance, Dilip Shanghvi, MD said: "Our Q2 performance reflects our focus on business improvement which has enabled a gradual recovery in all our businesses compared to Q1, despite market conditions that have not fully normalized. Sales of our specialty products have improved sequentially with Ilumya and Cequa reaching pre-Covid levels. We continue to focus on growing our topline, gaining market share, cost control and business continuity. We also continue to serve our patients and customers while ensuring safety of our employees."

    Sun Pharmaceutical Industries is a specialty generic manufacturing pharma company.

    Back to news list
Previous Stories :
More
Hot Pursuit News

Quick Links

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
91-22-25230011
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 05-Mar-2021
  •  ( 15:55) Shilpa Medicare gets USFDA nod for arthritis drug  
  •  ( 15:54) Sun Pharma subsidiary to acquire 12.5% stake in WRS Bioproducts  
  •  ( 15:54) Indiabulls Housing allots $150 million foreign currency convertible bonds  
  •  ( 15:54) European shares trading lower  
  •  ( 15:53) Asian markts close on a negative note  
  •  ( 15:53) Nifty closes below 15,000 mark  
  •  ( 15:53) Coal India declares second interim dividend  
  •  ( 15:52) Sensex drops 440 pts amid weak global cues, firm crude oil prices  
  •  ( 14:13) BEML appoints Deloitte Haskins & Sells LPP as consultant for demerger of non-core assets  
  •  ( 13:35) The Nifty index holds its 15,000 mark  
  •  ( 13:34) Indices experience intense volatility; metal and bank stocks in demand  
  •  ( 11:34) PVR launches 6-screen property in Forum Centre City Mall, Mysuru  
  •  ( 11:28) Equity indices trade sideways with losses  
  •  ( 10:49) PNB Housing Finance, Yes Bank join hands to offer customized retail loans  
  •  ( 10:10) Heranba Industries lists at Rs 900 per share vs issue price of Rs 627 apiece  
  •  ( 09:52) Dilip Buildcon receives LoA for two Karnataka-based projects  
  •  ( 09:45) BCPL Railway Infrastructure bags a LoA from Railway Vikas Nigam  
  •  ( 09:29) Positive market breadth  
  •  ( 09:25) Nifty drops below 15,000   
  •  ( 09:24) ISGEC Heavy Engg. secures a deal from Shree Cement to set up boilers  
  •  ( 09:22) Wipro acquires London-based Capco for $1.45 billion  
  •  ( 09:19) Market trading lower in early trade  
  •  ( 08:15) OPEC+ extends most oil output cuts into April  
  •  ( 08:09) US stocks drop on Thursday as Powell fails to ease rate fears  
Show News
05 March 2021 00:00
2386.75
(-1.29 %)
731.20
(-0.75 %)
3853.55
(-0.61 %)
5444.40
(-0.78 %)
9952.10
(-1.74 %)
532.40
(-1.31 %)
4489.40
(-1.86 %)
2543.25
(-1.55 %)
941.30
(-1.77 %)
1529.65
(-1.52 %)
2201.80
(0.23 %)
609.70
(-1.80 %)
1039.75
(-4.79 %)
1316.00
(-1.07 %)
208.75
(-0.45 %)
1923.75
(1.38 %)
1463.60
(0.10 %)
840.00
(-0.68 %)
7247.80
(1.60 %)
16774.45
(0.75 %)
108.75
(-1.85 %)
114.90
(1.95 %)
220.30
(-2.13 %)
2178.55
(0.13 %)
383.80
(-3.03 %)
610.95
(-1.24 %)
3007.00
(-1.34 %)
959.50
(-0.90 %)
1474.65
(0.29 %)
6810.25
(0.50 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.